For example, a meta-analysis showed that SOX2 is aberrantly expressed in head and neck cancer, and high SOX2 expression, in addition to high tumor grades, advanced TNM stages, lymph node metastasis and distant metastasis, predicts an unfavorable patient overall survival (OS)45. Here, SOX2 is linked to metastatic malignant neoplasm in the lymph nodes.